NCT06640361 2024-12-27A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.Phase 3 Recruiting40 enrolled
NCT00618319 2015-10-02An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)BiogenPhase 2 Completed20 enrolled